Capping Prescription Costs Act of 2025

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 2553 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 2553 To limit cost-sharing for prescription drugs, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES April 1, 2025 Mr. Horsford (for himself, Mr. Figures, Ms. Stansbury, Mr. Johnson of Georgia, Ms. Waters, Mrs. Cherfilus-McCormick, Mrs. Hayes, Mr. Thompson of Mississippi, and Ms. Norton) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To limit cost-sharing for prescription drugs, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Capping Prescription Costs Act of 2025''. SEC. 2. CAP ON PRESCRIPTION DRUG COST-SHARING. (a) Qualified Health Plans.--Section 1302(c) of the Patient Protection and Affordable Care Act (42 U.S.C. 18022(c)) is amended-- (1) in paragraph (3)(A)(i), by inserting ``, including cost-sharing with respect to prescription drugs covered by the plan'' after ``charges''; and (2) by adding at the end the following: ``(5) Prescription drug cost-sharing.-- ``(A) 2026.--For plan years beginning in 2026, the cost-sharing incurred under a health plan with respect to prescription drugs covered by the plan shall not exceed $2,000 per year for each enrolled individual, or $4,000 per year for each family. ``(B) 2027 and later.-- ``(i) In general.--In the case of any plan year beginning in a calendar year after 2026, the limitati